No Data
Top Premarket Gainers
12 Health Care Stocks Moving In Friday's Intraday Session
MediciNova (NASDAQ:MNOV) Shareholders Have Endured a 73% Loss From Investing in the Stock Five Years Ago
MediciNova Announces That The National Institutes Of Health Neurological Disorders And Stroke Has Awarded $22M For An Intermediate Size Expanded Access Protocol To Evaluate The Efficacy Of MN-166 In Amyotrophic Lateral Sclerosis
Express News | MediciNova Inc - Nih Awards $22 Million for Eap to Evaluate Mn-166 in ALS
Express News | Medicinova to Support Nih-Funded Expanded Access Clinical Trial to Evaluate Mn166 (Ibudilast) in Amyotrophic Lateral Sclerosis (ALS)